48,475
edits
Difference between revisions of "Epidermal growth factor receptor inhibitors"
Jump to navigation
Jump to search
Epidermal growth factor receptor inhibitors (view source)
Revision as of 16:13, 29 March 2012
, 16:13, 29 March 2012+cancer drugs
m |
(+cancer drugs) |
||
| Line 3: | Line 3: | ||
==Drugs== | ==Drugs== | ||
*[[Gefitinib]] (Iressa).<ref name=pmid20855837/> | *[[Gefitinib]] (Iressa).<ref name=pmid20855837/> | ||
*[[Erlotinib]] (Tarceva | *[[Erlotinib]] (Tarceva).<ref name=pmid20855837>{{cite journal |author=Sun Y, Ren Y, Fang Z, ''et al.'' |title=Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases |journal=J. Clin. Oncol. |volume=28 |issue=30 |pages=4616–20 |year=2010 |month=October |pmid=20855837 |doi=10.1200/JCO.2010.29.6038 |url=}}</ref> | ||
Note: | Note: | ||
| Line 11: | Line 11: | ||
*[[Lung adenocarcinoma]]. | *[[Lung adenocarcinoma]]. | ||
*[[Colorectal adenocarcinoma]]. | *[[Colorectal adenocarcinoma]]. | ||
*[[Cancer drugs]]. | |||
==References== | ==References== | ||